Innate immune memory in inflammatory arthritis.
Journal
Nature reviews. Rheumatology
ISSN: 1759-4804
Titre abrégé: Nat Rev Rheumatol
Pays: United States
ID NLM: 101500080
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
accepted:
21
07
2023
medline:
25
9
2023
pubmed:
7
9
2023
entrez:
6
9
2023
Statut:
ppublish
Résumé
The concept of immunological memory was demonstrated in antiquity when protection against re-exposure to pathogens was observed during the plague of Athens. Immunological memory has been linked with the adaptive features of T and B cells; however, in the past decade, evidence has demonstrated that innate immune cells can exhibit memory, a phenomenon called 'innate immune memory' or 'trained immunity'. Innate immune memory is currently being defined and is transforming our understanding of chronic inflammation and autoimmunity. In this Review, we provide an up-to-date overview of the memory-like features of innate immune cells in inflammatory arthritis and the crosstalk between chronic inflammatory milieu and cell reprogramming. Aberrant pro-inflammatory signalling, including cytokines, regulates the metabolic and epigenetic reprogramming of haematopoietic progenitors, leading to exacerbated inflammatory responses and osteoclast differentiation, in turn leading to bone destruction. Moreover, imprinted memory on mature cells including terminally differentiated osteoclasts alters responsiveness to therapies and modifies disease outcomes, commonly manifested by persistent inflammatory flares and relapse following medication withdrawal.
Identifiants
pubmed: 37674048
doi: 10.1038/s41584-023-01009-0
pii: 10.1038/s41584-023-01009-0
doi:
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
627-639Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR062173
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR068974
Pays : United States
Informations de copyright
© 2023. Springer Nature Limited.
Références
Vitetta, E. S. et al. Memory B and T cells. Annu. Rev. Immunol. 9, 193–217 (1991).
pubmed: 1910676
doi: 10.1146/annurev.iy.09.040191.001205
Netea, M. G., Quintin, J. & van der Meer, J. W. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355–361 (2011).
pubmed: 21575907
doi: 10.1016/j.chom.2011.04.006
Cerwenka, A. & Lanier, L. L. Natural killer cell memory in infection, inflammation and cancer. Nat. Rev. Immunol. 16, 112–123 (2016).
pubmed: 26806484
doi: 10.1038/nri.2015.9
Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).
pubmed: 27102489
pmcid: 5087274
doi: 10.1126/science.aaf1098
Brandi, P. et al. Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections. Cell Rep. 38, 110184 (2022).
pubmed: 34986349
pmcid: 8755442
doi: 10.1016/j.celrep.2021.110184
Netea, M. G. et al. Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell 181, 969–977 (2020).
pubmed: 32437659
pmcid: 7196902
doi: 10.1016/j.cell.2020.04.042
Kalafati, L. et al. Innate immune training of granulopoiesis promotes anti-tumor activity. Cell 183, 771–785.e712 (2020).
pubmed: 33125892
pmcid: 7599076
doi: 10.1016/j.cell.2020.09.058
Geller, A. E. et al. The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression. Nat. Commun. 13, 759 (2022).
pubmed: 35140221
pmcid: 8828725
doi: 10.1038/s41467-022-28407-4
Bekkering, S. et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell 172, 135–146.e139 (2018).
pubmed: 29328908
doi: 10.1016/j.cell.2017.11.025
Goldblatt, F. & O’Neill, S. G. Clinical aspects of autoimmune rheumatic diseases. Lancet 382, 797–808 (2013).
pubmed: 23993190
doi: 10.1016/S0140-6736(13)61499-3
Chaplin, D. D. Overview of the immune response. J. Allergy Clin. Immunol. 125, S3–S23 (2010).
pubmed: 20176265
pmcid: 2923430
doi: 10.1016/j.jaci.2009.12.980
Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775–787 (2008).
pubmed: 18510923
doi: 10.1016/j.cell.2008.05.009
Rawlings, D. J., Metzler, G., Wray-Dutra, M. & Jackson, S. W. Altered B cell signalling in autoimmunity. Nat. Rev. Immunol. 17, 421–436 (2017).
pubmed: 28393923
pmcid: 5523822
doi: 10.1038/nri.2017.24
Maschmeyer, P. et al. Immunological memory in rheumatic inflammation — a roadblock to tolerance induction. Nat. Rev. Rheumatol. 17, 291–305 (2021).
pubmed: 33824526
doi: 10.1038/s41584-021-00601-6
Gerards, A. H. et al. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial. Ann. Rheum. Dis. 62, 291–296 (2003).
pubmed: 12634224
pmcid: 1754491
doi: 10.1136/ard.62.4.291
Yocum, D. E. et al. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology 43, 992–999 (2004).
pubmed: 15014199
doi: 10.1093/rheumatology/keh155
Mangoni, A. A. et al. Relapse rates after elective discontinuation of anti-TNF therapy in rheumatoid arthritis: a meta-analysis and review of literature. BMC Rheumatol. 3, 10 (2019).
pubmed: 30886998
pmcid: 6408847
doi: 10.1186/s41927-019-0058-7
Haschka, J. et al. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Ann. Rheum. Dis. 75, 45–51 (2016).
pubmed: 25660991
doi: 10.1136/annrheumdis-2014-206439
Moore, J. et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 46, 2301–2309 (2002).
pubmed: 12355477
doi: 10.1002/art.10495
Jaime-Pérez, J. C. et al. Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort. Clin. Rheumatol. 41, 869–876 (2022).
pubmed: 34585327
doi: 10.1007/s10067-021-05931-0
Teng, Y. K. et al. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum. 52, 2272–2276 (2005).
pubmed: 16052541
doi: 10.1002/art.21219
Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172, 147–161.e112 (2018).
pubmed: 29328910
pmcid: 5766828
doi: 10.1016/j.cell.2017.11.034
Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176–190.e119 (2018).
pubmed: 29328912
doi: 10.1016/j.cell.2017.12.031
Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23, 89–100.e105 (2018).
pubmed: 29324233
doi: 10.1016/j.chom.2017.12.010
Christ, A. et al. Western diet triggers NLRP3-dependent innate immune reprogramming. Cell 172, 162–175 e114 (2018).
pubmed: 29328911
pmcid: 6324559
doi: 10.1016/j.cell.2017.12.013
Chavakis, T., Mitroulis, I. & Hajishengallis, G. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat. Immunol. 20, 802–811 (2019).
pubmed: 31213716
pmcid: 6709414
doi: 10.1038/s41590-019-0402-5
Theofilopoulos, A. N. et al. Sensors of the innate immune system: their link to rheumatic diseases. Nat. Rev. Rheumatol. 6, 146–156 (2010).
pubmed: 20142813
pmcid: 4437225
doi: 10.1038/nrrheum.2009.278
Murray, P. J. Macrophage polarization. Annu. Rev. Physiol. 79, 541–566 (2017).
pubmed: 27813830
doi: 10.1146/annurev-physiol-022516-034339
Adamopoulos, I. E. et al. IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis. Ann. Rheum. Dis. 74, 1284–1292 (2015).
pubmed: 24567524
doi: 10.1136/annrheumdis-2013-204782
Adamopoulos, I. E. et al. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J. Immunol. 187, 951–959 (2011).
pubmed: 21670317
doi: 10.4049/jimmunol.1003986
Suzuki, E. et al. T cell-independent mechanisms associated with neutrophil extracellular trap formation and selective autophagy in IL-17A-mediated epidermal hyperplasia. J. Immunol. 197, 4403–4412 (2016).
pubmed: 27798153
doi: 10.4049/jimmunol.1600383
Li, X. et al. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell 185, 1709–1727.e1718 (2022).
pubmed: 35483374
pmcid: 9106933
doi: 10.1016/j.cell.2022.03.043
Stark, M. A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22, 285–294 (2005).
pubmed: 15780986
doi: 10.1016/j.immuni.2005.01.011
Mamedov, M. R. et al. A macrophage colony-stimulating-factor-producing γδ T cell subset prevents malarial parasitemic recurrence. Immunity 48, 350–363.e357 (2018).
pubmed: 29426701
pmcid: 5956914
doi: 10.1016/j.immuni.2018.01.009
Nguyen, C. T. et al. Peripheral γδ T cells regulate neutrophil expansion and recruitment in experimental psoriatic arthritis. Arthritis Rheumatol. 74, 1524–1534 (2022).
pubmed: 35320625
pmcid: 9427669
doi: 10.1002/art.42124
Venken, K. et al. RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in spondyloarthritis patients. Nat. Commun. 10, 9 (2019).
pubmed: 30602780
pmcid: 6315029
doi: 10.1038/s41467-018-07911-6
Al-Mossawi, M. H. et al. Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nat. Commun. 8, 1510 (2017).
pubmed: 29142230
pmcid: 5688161
doi: 10.1038/s41467-017-01771-2
Louis, C. et al. NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS. J. Exp. Med. https://doi.org/10.1084/jem.20191421 (2020).
doi: 10.1084/jem.20191421
pubmed: 32221522
pmcid: 7201915
Oduro, K. A. Jr et al. Myeloid skewing in murine autoimmune arthritis occurs in hematopoietic stem and primitive progenitor cells. Blood 120, 2203–2213 (2012).
pubmed: 22855602
pmcid: 3447779
doi: 10.1182/blood-2011-11-391342
Chen, T. H., Swarnkar, G., Mbalaviele, G. & Abu-Amer, Y. Myeloid lineage skewing due to exacerbated NF-κB signaling facilitates osteopenia in Scurfy mice. Cell Death Dis. 6, e1723 (2015).
pubmed: 25880090
pmcid: 4650554
doi: 10.1038/cddis.2015.87
Haringman, J. J. et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis. 64, 834–838 (2005).
pubmed: 15576415
doi: 10.1136/ard.2004.029751
Soler Palacios, B. et al. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile. J. Pathol. 235, 515–526 (2015).
pubmed: 25319955
doi: 10.1002/path.4466
Katschke, K. J. Jr. et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 44, 1022–1032 (2001).
pubmed: 11352233
doi: 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N
Lacerte, P. et al. Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists. Arthritis Res. Ther. 18, 10 (2016).
pubmed: 26759164
pmcid: 4718023
doi: 10.1186/s13075-015-0901-1
van Kuijk, A. W., Reinders-Blankert, P., Smeets, T. J., Dijkmans, B. A. & Tak, P. P. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann. Rheum. Dis. 65, 1551–1557 (2006).
pubmed: 16728461
pmcid: 1798447
doi: 10.1136/ard.2005.050963
Zhu, H. et al. CD16
pubmed: 27917174
pmcid: 5116853
doi: 10.3389/fimmu.2016.00512
Hepburn, A. L., Mason, J. C. & Davies, K. A. Expression of Fcγ and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology 43, 547–554 (2004).
pubmed: 14747618
doi: 10.1093/rheumatology/keh112
Katsiari, C. G. et al. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus. Clin. Immunol. 103, 54–62 (2002).
pubmed: 11987985
doi: 10.1006/clim.2001.5172
Mohammadi, S., Memarian, A., Sedighi, S., Behnampour, N. & Yazdani, Y. Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: a crucial role for aryl hydrocarbon receptor. Autoimmunity 51, 199–209 (2018).
pubmed: 30289282
doi: 10.1080/08916934.2018.1494161
Steinbach, F. et al. Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann. Rheum. Dis. 59, 283–288 (2000).
pubmed: 10733475
pmcid: 1753112
doi: 10.1136/ard.59.4.283
Frostegård, J. et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 52, 192–200 (2005).
pubmed: 15641060
doi: 10.1002/art.20780
McGarry, T. et al. Rheumatoid arthritis CD14
doi: 10.1002/cti2.1237
Gordon, R. A., Grigoriev, G., Lee, A., Kalliolias, G. D. & Ivashkiv, L. B. The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment. Arthritis Rheum. 64, 3119–3128 (2012).
pubmed: 22614743
pmcid: 3449023
doi: 10.1002/art.34544
Hu, X. & Ivashkiv, L. B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31, 539–550 (2009).
pubmed: 19833085
pmcid: 2774226
doi: 10.1016/j.immuni.2009.09.002
Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling. Immunity 39, 454–469 (2013).
pubmed: 24012417
doi: 10.1016/j.immuni.2013.08.009
Ivashkiv, L. B. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545–558 (2018).
pubmed: 29921905
pmcid: 6340644
doi: 10.1038/s41577-018-0029-z
Fanucchi, S., Dominguez-Andres, J., Joosten, L. A. B., Netea, M. G. & Mhlanga, M. M. The intersection of epigenetics and metabolism in trained immunity. Immunity 54, 32–43 (2021).
pubmed: 33220235
doi: 10.1016/j.immuni.2020.10.011
Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375–388 (2020).
pubmed: 32132681
pmcid: 7186935
doi: 10.1038/s41577-020-0285-6
Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015).
pubmed: 25786174
doi: 10.1016/j.immuni.2015.02.005
Arts, R. J., Joosten, L. A. & Netea, M. G. Immunometabolic circuits in trained immunity. Semin. Immunol. 28, 425–430 (2016).
pubmed: 27686054
doi: 10.1016/j.smim.2016.09.002
McNearney, T., Speegle, D., Lawand, N., Lisse, J. & Westlund, K. N. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J. Rheumatol. 27, 739–745 (2000).
pubmed: 10743819
pmcid: 7894989
Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 9, e97501 (2014).
pubmed: 24887281
pmcid: 4041724
doi: 10.1371/journal.pone.0097501
Rodgers, L. C. et al. The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretion. Rheumatology 59, 869–878 (2020).
pubmed: 31497857
doi: 10.1093/rheumatology/kez378
Meyer, A. et al. Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2022-223284 (2023).
doi: 10.1136/ard-2022-223284
pubmed: 36593091
Cheng, S. C. et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).
pubmed: 25258083
pmcid: 4226238
doi: 10.1126/science.1250684
Ballestar, E. & Li, T. New insights into the epigenetics of inflammatory rheumatic diseases. Nat. Rev. Rheumatol. 13, 593–605 (2017).
pubmed: 28905855
doi: 10.1038/nrrheum.2017.147
Zhang, Z. et al. H3K4 tri-methylation breadth at transcription start sites impacts the transcriptome of systemic lupus erythematosus. Clin. Epigenetics 8, 14 (2016).
pubmed: 26839600
pmcid: 4736279
doi: 10.1186/s13148-016-0179-4
Dai, Y., Zhang, L., Hu, C. & Zhang, Y. Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Clin. Exp. Rheumatol. 28, 158–168 (2010).
pubmed: 20483040
Wu, W. et al. Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis. Cell Mol. Immunol. 16, 694–705 (2019).
pubmed: 29844591
doi: 10.1038/s41423-018-0037-8
Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P. & Gilkeson, G. S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 111, 539–552 (2003).
pubmed: 12588892
pmcid: 151922
doi: 10.1172/JCI16153
Zhao, Z. et al. Inhibition of histone H3 lysine-27 demethylase activity relieves rheumatoid arthritis symptoms via repression of IL6 transcription in macrophages. Front. Immunol. 13, 818070 (2022).
pubmed: 35371061
pmcid: 8965057
doi: 10.3389/fimmu.2022.818070
Lin, Y. C. et al. Tumor necrosis factor-α inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification. Mol. Immunol. 83, 82–91 (2017).
pubmed: 28113136
doi: 10.1016/j.molimm.2017.01.009
Gebert, L. F. R. & MacRae, I. J. Regulation of microRNA function in animals. Nat. Rev. Mol. Cell Biol. 20, 21–37 (2019).
pubmed: 30108335
pmcid: 6546304
doi: 10.1038/s41580-018-0045-7
Seeley, J. J. et al. Induction of innate immune memory via microRNA targeting of chromatin remodelling factors. Nature 559, 114–119 (2018).
pubmed: 29950719
pmcid: 6044474
doi: 10.1038/s41586-018-0253-5
Kurowska-Stolarska, M. et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl Acad. Sci. USA 108, 11193–11198 (2011).
pubmed: 21690378
pmcid: 3131377
doi: 10.1073/pnas.1019536108
Yang, B. et al. Decreased miR-4512 levels in monocytes and macrophages of individuals with systemic lupus erythematosus contribute to innate immune activation and neutrophils NETosis by targeting TLR4 and CXCL2. Front. Immunol. 12, 756825 (2021).
pubmed: 34721432
pmcid: 8552026
doi: 10.3389/fimmu.2021.756825
Rodríguez-Ubreva, J. et al. Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis. Ann. Rheum. Dis. 78, 1505–1516 (2019).
pubmed: 31371305
doi: 10.1136/annrheumdis-2019-215355
de Andres, M. C. et al. Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate. Arthritis Res. Ther. 17, 233 (2015).
pubmed: 26330155
pmcid: 4556005
doi: 10.1186/s13075-015-0748-5
Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019).
pubmed: 31061532
pmcid: 6602051
doi: 10.1038/s41590-019-0378-1
Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295–1306 (2020).
pubmed: 32601335
doi: 10.1038/s41591-020-0939-8
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124–1136 (2007).
pubmed: 18083102
doi: 10.1016/j.cell.2007.10.034
Adomati, T. et al. Dead cells induce innate anergy via Mertk after acute viral infection. Cell Rep. 30, 3671–3681.e3675 (2020).
pubmed: 32187540
doi: 10.1016/j.celrep.2020.02.101
de Jong, H. M. Y. et al. Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-α inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial. Arthritis Res. Ther. 21, 208 (2019).
pubmed: 31521192
pmcid: 6744710
doi: 10.1186/s13075-019-1998-4
Degboé, Y. et al. Polarization of rheumatoid macrophages by TNF targeting through an IL-10/STAT3 mechanism. Front. Immunol. 10, 3 (2019).
pubmed: 30713533
pmcid: 6345709
doi: 10.3389/fimmu.2019.00003
Municio, C. et al. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism. Ann. Rheum. Dis. 77, 752–759 (2018).
pubmed: 29431121
doi: 10.1136/annrheumdis-2017-212537
Xia, M. et al. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immunity 39, 470–481 (2013).
pubmed: 24012418
doi: 10.1016/j.immuni.2013.08.016
Tsukasaki, M. & Takayanagi, H. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol. 19, 626–642 (2019).
pubmed: 31186549
doi: 10.1038/s41577-019-0178-8
Teitelbaum, S. L. & Ross, F. P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638–649 (2003).
pubmed: 12897775
doi: 10.1038/nrg1122
Fierro, F. A., Nolta, J. A. & Adamopoulos, I. E. Concise review: stem cells in osteoimmunology. Stem Cell 35, 1461–1467 (2017).
doi: 10.1002/stem.2625
Adamopoulos, I. E. et al. Synovial fluid macrophages are capable of osteoclast formation and resorption. J. Pathol. 208, 35–43 (2006).
pubmed: 16278818
doi: 10.1002/path.1891
Adamopoulos, I. E. & Mellins, E. D. Alternative pathways of osteoclastogenesis in inflammatory arthritis. Nat. Rev. Rheumatol. 11, 189–194 (2015).
pubmed: 25422000
doi: 10.1038/nrrheum.2014.198
Adamopoulos, I. E. et al. Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors. Arthritis Res. Ther. 12, R29 (2010).
pubmed: 20167120
pmcid: 2875663
doi: 10.1186/ar2936
Shin, H. S. et al. Crosstalk among IL-23 and DNAX activating protein of 12 kDa-dependent pathways promotes osteoclastogenesis. J. Immunol. 194, 316–324 (2015).
pubmed: 25452564
doi: 10.4049/jimmunol.1401013
Yarilina, A., Xu, K., Chen, J. & Ivashkiv, L. B. TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc. Natl Acad. Sci. USA 108, 1573–1578 (2011).
pubmed: 21220349
pmcid: 3029683
doi: 10.1073/pnas.1010030108
Furuya, H. et al. Interleukin-23 regulates inflammatory osteoclastogenesis via activation of CLEC5A
doi: 10.1002/art.42478
pubmed: 36787107
Andreev, D. et al. Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin. J. Clin. Invest. 130, 4811–4830 (2020).
pubmed: 32773408
pmcid: 7456234
doi: 10.1172/JCI134214
Nishikawa, K. et al. DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway. Nat. Med. 21, 281–287 (2015).
pubmed: 25706873
doi: 10.1038/nm.3774
Indo, Y. et al. Metabolic regulation of osteoclast differentiation and function. J. Bone Miner. Res. 28, 2392–2399 (2013).
pubmed: 23661628
doi: 10.1002/jbmr.1976
Murata, K. et al. Hypoxia-sensitive COMMD1 integrates signaling and cellular metabolism in human macrophages and suppresses osteoclastogenesis. Immunity 47, 66–79.e65 (2017).
pubmed: 28723554
pmcid: 5568808
doi: 10.1016/j.immuni.2017.06.018
Kim, K., Shin, Y., Kim, J., Ulmer, T. S. & An, W. H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis. Epigenetics Chromatin 11, 23 (2018).
pubmed: 29807539
pmcid: 5971420
doi: 10.1186/s13072-018-0193-1
Xia, Y. et al. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis. Nat. Commun. 13, 3920 (2022).
pubmed: 35798734
pmcid: 9263175
doi: 10.1038/s41467-022-31475-1
Kurotaki, D., Yoshida, H. & Tamura, T. Epigenetic and transcriptional regulation of osteoclast differentiation. Bone 138, 115471 (2020).
pubmed: 32526404
doi: 10.1016/j.bone.2020.115471
Kameda, Y. et al. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12. J. Bone Miner. Res. 28, 2463–2475 (2013).
pubmed: 23677868
doi: 10.1002/jbmr.1989
Moorlag, S. et al. An integrative genomics approach identifies KDM4 as a modulator of trained immunity. Eur. J. Immunol. 52, 431–446 (2022).
pubmed: 34821391
doi: 10.1002/eji.202149577
McDonald, M. M. et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell 184, 1940 (2021).
pubmed: 33798441
pmcid: 8024244
doi: 10.1016/j.cell.2021.03.010
Tsourdi, E. et al. Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 105, 11–17 (2017).
pubmed: 28789921
doi: 10.1016/j.bone.2017.08.003
Kiesel, J. R., Buchwald, Z. S. & Aurora, R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J. Immunol. 182, 5477–5487 (2009).
pubmed: 19380796
doi: 10.4049/jimmunol.0803897
Li, H. et al. Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4
pubmed: 20304810
pmcid: 2910608
doi: 10.1182/blood-2009-11-255026
Ibáñez, L. et al. Inflammatory osteoclasts prime TNFα-producing CD4
pubmed: 27161765
doi: 10.1002/jbmr.2868
Madel, M. B. et al. Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1. Elife https://doi.org/10.7554/eLife.54493 (2020).
doi: 10.7554/eLife.54493
pubmed: 32400390
pmcid: 7220377
Prevoo, M. L. et al. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br. J. Rheumatol. 35, 1101–1105 (1996).
pubmed: 8948296
doi: 10.1093/rheumatology/35.11.1101
Alivernini, S. et al. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission? Ann. Rheum. Dis. 76, 1228–1236 (2017).
pubmed: 28119289
doi: 10.1136/annrheumdis-2016-210424
Tokai, N. et al. Predictive value of bone destruction and duration of clinical remission for subclinical synovitis in rheumatoid arthritis patients. Mod. Rheumatol. 25, 540–545 (2015).
pubmed: 25496404
doi: 10.3109/14397595.2014.987421
Knowlton, N. et al. The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states. Arthritis Rheum. 60, 892–900 (2009).
pubmed: 19248118
pmcid: 2758237
doi: 10.1002/art.24298
Misharin, A. V. et al. Nonclassical Ly6C
pubmed: 25373902
pmcid: 4223808
doi: 10.1016/j.celrep.2014.09.032
van Nies, J. A. et al. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann. Rheum. Dis. 73, 861–870 (2014).
pubmed: 23572339
doi: 10.1136/annrheumdis-2012-203130
van Mens, L. J. J. et al. Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate. Ann. Rheum. Dis. 78, 610–616 (2019).
pubmed: 30808625
doi: 10.1136/annrheumdis-2018-214746
Krijbolder, D. I. et al. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet 400, 283–294 (2022).
pubmed: 35871815
doi: 10.1016/S0140-6736(22)01193-X
Aeberli, D. et al. Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis. RMD Open 2, e000079 (2016).
pubmed: 26819749
pmcid: 4716562
doi: 10.1136/rmdopen-2015-000079
Vos, A. C. et al. Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology 140, 221–230 (2011).
pubmed: 20955706
doi: 10.1053/j.gastro.2010.10.008
Saleem, B. et al. Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study. Ann. Rheum. Dis. 71, 1316–1321 (2012).
pubmed: 22294638
doi: 10.1136/annrheumdis-2011-200548
Chen, H. H. et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann. Rheum. Dis. 72, 1206–1211 (2013).
pubmed: 22941768
doi: 10.1136/annrheumdis-2012-201593
Mikuls, T. R. et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum. 64, 3522–3530 (2012).
pubmed: 22736291
doi: 10.1002/art.34595
Sandberg, M. E., Bengtsson, C., Klareskog, L., Alfredsson, L. & Saevarsdottir, S. Recent infections are associated with decreased risk of rheumatoid arthritis: a population-based case-control study. Ann. Rheum. Dis. 74, 904–907 (2015).
pubmed: 25656683
doi: 10.1136/annrheumdis-2014-206493
Biswas, S. K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475–487 (2009).
pubmed: 19781994
doi: 10.1016/j.it.2009.07.009
Jeljeli, M. et al. Macrophage immune memory controls endometriosis in mice and humans. Cell Rep. 33, 108325 (2020).
pubmed: 33147452
doi: 10.1016/j.celrep.2020.108325
Bekkering, S. et al. Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler. Thromb. Vasc. Biol. 34, 1731–1738 (2014).
pubmed: 24903093
doi: 10.1161/ATVBAHA.114.303887
Geng, S. et al. The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat. Commun. 7, 13436 (2016).
pubmed: 27824038
pmcid: 5105176
doi: 10.1038/ncomms13436
Fuentelsaz-Romero, S. et al. The macrophage reprogramming ability of antifolates reveals soluble CD14 as a potential biomarker for methotrexate response in rheumatoid arthritis. Front. Immunol. 12, 776879 (2021).
pubmed: 34804067
pmcid: 8602851
doi: 10.3389/fimmu.2021.776879
Vaugelade, J., Pinchinat, S., Guiella, G., Elguero, E. & Simondon, F. Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso. Br. Med. J. 329, 1309 (2004).
doi: 10.1136/bmj.38261.496366.82
Kleinnijenhuis, J. et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci. USA 109, 17537–17542 (2012).
pubmed: 22988082
pmcid: 3491454
doi: 10.1073/pnas.1202870109
Quintin, J. et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12, 223–232 (2012).
pubmed: 22901542
doi: 10.1016/j.chom.2012.06.006
Jeljeli, M. et al. Trained immunity modulates inflammation-induced fibrosis. Nat. Commun. 10, 5670 (2019).
pubmed: 31827093
pmcid: 6906311
doi: 10.1038/s41467-019-13636-x
Saz-Leal, P. et al. Targeting SHIP-1 in myeloid cells enhances trained immunity and boosts response to infection. Cell Rep. 25, 1118–1126 (2018).
pubmed: 30380404
pmcid: 6226423
doi: 10.1016/j.celrep.2018.09.092
Foster, S. L., Hargreaves, D. C. & Medzhitov, R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972–978 (2007).
pubmed: 17538624
doi: 10.1038/nature05836
Cunningham, K. T., Finlay, C. M. & Mills, K. H. G. Helminth imprinting of hematopoietic stem cells sustains anti-inflammatory trained innate immunity that attenuates autoimmune disease. J. Immunol. 206, 1618–1630 (2021).
pubmed: 33579723
doi: 10.4049/jimmunol.2001225
Martinez-Gonzalez, I. et al. Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity 45, 198–208 (2016).
pubmed: 27421705
doi: 10.1016/j.immuni.2016.06.017
Ardain, A. et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature 570, 528–532 (2019).
pubmed: 31168092
pmcid: 6626542
doi: 10.1038/s41586-019-1276-2
Naik, S. et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature 550, 475–480 (2017).
pubmed: 29045388
pmcid: 5808576
doi: 10.1038/nature24271
Hamada, A., Torre, C., Drancourt, M. & Ghigo, E. Trained immunity carried by non-immune cells. Front. Microbiol. https://doi.org/10.3389/fmicb.2018.03225 (2019).
doi: 10.3389/fmicb.2018.03225
pubmed: 30800104
pmcid: 6375898
Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807–819 (2016).
pubmed: 27866838
pmcid: 5742541
doi: 10.1016/j.cmet.2016.10.008
Jentho, E. et al. Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme. Proc. Natl Acad. Sci. USA https://doi.org/10.1073/pnas.2102698118 (2021).
doi: 10.1073/pnas.2102698118
pubmed: 34663697
pmcid: 8545490
Ospelt, C. et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 58, 3684–3692 (2008).
pubmed: 19035519
doi: 10.1002/art.24140
Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. 9, 789 (2018).
pubmed: 29476097
pmcid: 5824882
doi: 10.1038/s41467-018-02892-y
Nygaard, G. & Firestein, G. S. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat. Rev. Rheumatol. 16, 316–333 (2020).
pubmed: 32393826
pmcid: 7987137
doi: 10.1038/s41584-020-0413-5
Chang, S. K. et al. Cadherin-11 regulates fibroblast inflammation. Proc. Natl Acad. Sci. USA 108, 8402–8407 (2011).
pubmed: 21536877
pmcid: 3100978
doi: 10.1073/pnas.1019437108
Noss, E. H., Chang, S. K., Watts, G. F. & Brenner, M. B. Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement. Arthritis Rheum. 63, 3768–3778 (2011).
pubmed: 22127696
pmcid: 5507176
doi: 10.1002/art.30630
Lee, D. M. et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 315, 1006–1010 (2007).
pubmed: 17255475
doi: 10.1126/science.1137306
Lee, A. et al. Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 65, 928–938 (2013).
pubmed: 23335080
pmcid: 3618592
doi: 10.1002/art.37853
Sohn, C. et al. Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol. 67, 86–95 (2015).
pubmed: 25199798
pmcid: 4455921
doi: 10.1002/art.38871
Ospelt, C., Gay, S. & Klein, K. Epigenetics in the pathogenesis of RA. Semin. Immunopathol. 39, 409–419 (2017).
pubmed: 28324153
doi: 10.1007/s00281-017-0621-5
Ai, R. et al. Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes. Nat. Commun. 9, 1921 (2018).
pubmed: 29765031
pmcid: 5953939
doi: 10.1038/s41467-018-04310-9
Yan, M. et al. ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts. Nat. Immunol. 23, 1330–1341 (2022).
pubmed: 35999392
doi: 10.1038/s41590-022-01285-0
Friščić, J. et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54, 1002–1021.e1010 (2021).
pubmed: 33761330
doi: 10.1016/j.immuni.2021.03.003
Koedderitzsch, K., Zezina, E., Li, L., Herrmann, M. & Biesemann, N. TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A. Sci. Rep. 11, 19385 (2021).
pubmed: 34588517
pmcid: 8481345
doi: 10.1038/s41598-021-98651-z
Friščić, J. et al. Reset of inflammatory priming of joint tissue and reduction of the severity of arthritis flares by bromodomain inhibition. Arthritis Rheumatol. https://doi.org/10.1002/art.42378 (2022).
doi: 10.1002/art.42378